First Quadrant’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,373
| Closed | -$847K | – | 508 |
|
|
2021
Q4 | $847K | Hold |
8,373
| – | – | 0.09% | 188 |
|
|
2021
Q3 | $772K | Hold |
8,373
| – | – | 0.09% | 194 |
|
|
2021
Q2 | $858K | Sell |
8,373
-1,282
| -13% | -$129K | 0.1% | 186 |
|
|
2021
Q1 | $942K | Hold |
9,655
| – | – | 0.1% | 171 |
|
|
2020
Q4 | $744K | Sell |
9,655
-968
| -9% | -$74.9K | 0.07% | 188 |
|
|
2020
Q3 | $782K | Sell |
10,623
-2,363
| -18% | -$190K | 0.1% | 174 |
|
|
2020
Q2 | $954K | Sell |
12,986
-8,833
| -40% | -$693K | 0.13% | 173 |
|
|
2020
Q1 | $1.26M | Buy |
21,819
+18,119
| +490% | +$1.26M | 0.18% | 135 |
|
|
2019
Q4 | $291K | Hold |
3,700
| – | – | 0.02% | 365 |
|
|
2019
Q3 | $253K | Sell |
3,700
-24,481
| -87% | -$1.64M | 0.02% | 388 |
|
|
2019
Q2 | $2.24M | Sell |
28,181
-21,137
| -43% | -$1.68M | 0.16% | 172 |
|
|
2019
Q1 | $4.14M | Buy |
49,318
+16,370
| +50% | +$1.71M | 0.32% | 70 |
|
|
2018
Q4 | $3.88M | Buy |
32,948
+1,799
| +6% | +$208K | 0.31% | 67 |
|
|
2018
Q3 | $3.75M | Sell |
31,149
-6,701
| -18% | -$832K | 0.08% | 234 |
|
|
2018
Q2 | $4.36M | Buy |
37,850
+15,191
| +67% | +$1.66M | 0.08% | 245 |
|
|
2018
Q1 | $1.95M | Hold |
22,659
| – | – | 0.04% | 327 |
|
|
2017
Q4 | $1.68M | Buy |
22,659
+2,475
| +12% | +$166K | 0.03% | 371 |
|
|
2017
Q3 | $1.17M | Sell |
20,184
-1,875
| -8% | -$111K | 0.02% | 414 |
|
|
2017
Q2 | $1.41M | Buy |
22,059
+3,459
| +19% | +$213K | 0.03% | 385 |
|
|
2017
Q1 | $1.07M | Hold |
18,600
| – | – | 0.02% | 447 |
|
|
2016
Q4 | $1.14M | Hold |
18,600
| – | – | 0.02% | 424 |
|
|
2016
Q3 | $1.29M | Hold |
18,600
| – | – | 0.03% | 401 |
|
|
2016
Q2 | $1.04M | Sell |
18,600
-1,400
| -7% | -$84.4K | 0.02% | 377 |
|
|
2016
Q1 | $1.21M | Hold |
20,000
| – | – | 0.03% | 368 |
|
|
2015
Q4 | $1.28M | Hold |
20,000
| – | – | 0.03% | 353 |
|
|
2015
Q3 | $1.34M | Sell |
20,000
-2,200
| -10% | -$156K | 0.03% | 340 |
|
|
2015
Q2 | $1.52M | Hold |
22,200
| – | – | 0.03% | 318 |
|
|
2015
Q1 | $1.23M | Sell |
22,200
-1,200
| -5% | -$61.5K | 0.03% | 328 |
|
|
2014
Q4 | $1.2M | Hold |
23,400
| – | – | 0.03% | 331 |
|
|
2014
Q3 | $862K | Sell |
23,400
-1,200
| -5% | -$43.3K | 0.02% | 381 |
|
|
2014
Q2 | $961K | Sell |
24,600
-2,000
| -8% | -$74.2K | 0.02% | 390 |
|
|
2014
Q1 | $1M | Sell |
26,600
-2,800
| -10% | -$97.8K | 0.02% | 369 |
|
|
2013
Q4 | $1.11M | Sell |
29,400
-9,800
| -25% | -$375K | 0.03% | 368 |
|
|
2013
Q3 | $1.7M | Sell |
39,200
-7,200
| -16% | -$289K | 0.04% | 317 |
|
|
2013
Q2 | $1.68M | Buy |
+46,400
| New | +$1.41M | 0.04% | 310 |
|
Other funds holding USNA
First Quadrant's USNA Position: Q1 2022 in Review
First Quadrant sold out of Usana Health Sciences (USNA) in Q1 2022, closing a stake of 8,373 shares — an estimated $847K sold.
First Quadrant first reported a position in USNA in Q2 2013 and held it in 35 quarters. The position peaked at $4.36M in Q2 2018. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.
- First Quadrant reported no remaining Usana Health Sciences position as of Q1 2022 after selling out during the quarter.
- First Quadrant sold 8,373 Usana Health Sciences shares in Q1 2022, an estimated $847K.
- First Quadrant first reported a position in Usana Health Sciences in Q2 2013 and held it in 35 quarters.
- First Quadrant's Usana Health Sciences position peaked at $4.36M in Q2 2018.
- 179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.
Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.